 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
 |
 |
 |
 |
 |
 |
Keywords: |
 |
Valproic Acid, Temodar |
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1914
NCT00313664
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: Y
Recurrent: N
Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
04/21/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Radiation. |
 |
 |
 |
 |
Contact: |
 |
National Cancer Institute NCI Cheryl Royce, CRNP, Clinical Director Neuro-oncology Branch 9030 Old Georgetown Road Bethesda, MD 20892 Phone:866-251-9686 Click here to send an email Website: home.ccr.cancer.gov/nob/ |
 |
 |
|
|